# Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics' stock sees mixed sentiment following a public offering, with analysts maintaining positive ratings despite recent price drops. Social media buzz highlights the potential of their eczema drugs as Dupixent rivals.

### About Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. Common Stock (APGE) is a publicly traded stock in the healthcare sector focused on developing biologic drugs.  
Apogee Therapeutics, Inc. uses the ticker $APGE for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Apogee Therapeutics, Inc. (APGE) mentions hit [---] which is 217% higher than it's daily average.
- Apogee Therapeutics, Inc. (APGE) creators hit [---] which is 161% higher than it's daily average.
- Apogee Therapeutics, Inc. (APGE) social dominance hit [------] which is 114% higher than it's daily average.
- Apogee Therapeutics, Inc. (APGE) trading volume is up 13.06% from the previous week.
- Apogee Therapeutics, Inc. (APGE) social dominance is up 262.96% from the previous [--] months.
- Apogee Therapeutics, Inc. (APGE) engagements is up 159.94% from the previous year.
- Apogee Therapeutics, Inc. (APGE) mentions is up 106.47% from the previous month.
- Apogee Therapeutics, Inc. (APGE) posts created is up 130.43% from the previous week.

### Price: $67.80
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$apge/time-series/close.tsv)  
The stock price has declined following a recent public offering due to valuation concerns and price drops post-offering, despite positive analyst sentiment and the drug's potential. Social media sentiment remains high, but recent price action indicates investor caution.  

24-Hour: -3.19%
7-Day: 8.9%
30-Day: -16.08%

1-Year High: $82.40 on 2026-01-14  
1-Year Low: $28.80 on 2025-04-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$apge/time-series/alt_rank.tsv)  
Apogee Therapeutics, Inc. (APGE) is currently AltRank #367 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +737  
[--] Month: [---] +82  
[--] Months: [---] +342  
[--] Year: [---] [----]  
1-Year High: [-----] on 2025-07-27  
1-Year Low: [--] on 2025-03-15  
  
  
### Galaxy Score: [--]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$apge/time-series/galaxy_score.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +4  
[--] Month: [--] +6  
[--] Months: [--] +7  
[--] Year: [--] +10  
1-Year High: [--] on 2025-03-17  
1-Year Low: [--] on 2025-07-31  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$apge/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] +20%  
[--] Month: [-------] +157%  
[--] Months: [---------] +27%  
[--] Year: [---------] +160%  
1-Year High: [-------] on 2025-07-07  
1-Year Low: [---] on 2025-11-09  

Engagements by network (24h):
News: [--]
X: [------]
TikTok: [--]
Reddit: [--]
YouTube: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$apge/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
[--] Week: [---] +24%  
[--] Month: [---] +106%  
[--] Months: [-----] -22%  
[--] Year: [-----] +129%  
1-Year High: [---] on 2025-07-07  
1-Year Low: [--] on 2025-09-06  

Mentions by network (24h):
News: [--]
X: [---]
TikTok: [--]
Reddit: [--]
YouTube: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$apge/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Apogee Therapeutics, Inc. (APGE) in the last [--] hours which is up 33% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +8.60%  
[--] Month: [---] +100%  
[--] Months: [---] -51%  
[--] Year: [-----] +178%  
1-Year High: [---] on 2025-07-07  
1-Year Low: [--] on 2025-09-06  

The most influential creators that mention Apogee Therapeutics, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]     | [------]      |
| [@A_May_MD](/creator/twitter/A_May_MD)               | [--]    | [------]    | [--]     | [-----]       |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | [--]    | [-----]     | [--]    | [-----]       |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | [--]    | [------]    | [--]     | [---]         |
| [@tradingsssss](/creator/twitter/tradingsssss)       | [--]    | [-----]     | [--]     | [---]         |
| [@JoseRestonVA](/creator/twitter/JoseRestonVA)       | [--]    | [-----]     | [--]     | [---]         |
| [@natty100338](/creator/twitter/natty100338)         | [--]    | [-----]     | [--]     | [---]         |
| [@Quantumup1](/creator/twitter/Quantumup1)           | [--]    | [-----]     | [--]     | [--]          |
| [@cluelessbio](/creator/twitter/cluelessbio)         | [--]    | [---]       | [--]     | [--]          |
| [@semodough](/creator/twitter/semodough)             | [--]   | [------]    | [--]     | [--]          |

[View More](/list/creators/$apge/100)
  
  
### Sentiment: 71%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$apge/time-series/sentiment.tsv)  
Current Value: 71%  
Daily Average: 81%  
[--] Week: 75% -21%  
[--] Month: 65% -13%  
[--] Months: 65% -31%  
[--] Year: 65% -14%  
1-Year High: 100% on 2025-03-04  
1-Year Low: 22% on 2025-02-27  

Most Supportive Themes:
- Analyst Ratings: (35%) Analysts are reiterating 'Buy' ratings and providing positive price targets for APGE.
- Eczema Drug Potential: (20%) APGE's eczema drugs are highlighted as potential rivals to Dupixent, generating significant interest.
  
Most Critical Themes:
- Initial Price Drop Post-Offering: (10%) The public offering, while closed, initially caused a price drop, indicating some investor concern.
- Price Decrease Post-Offering Announcement: (10%) The stock experienced a price decrease after the announcement of the public offering, which may be a concern for some investors.
  
  
  
### Social Dominance: 0.015%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$apge/time-series/social_dominance.tsv)  
Current Value: 0.015%  
Daily Average: 0.00917%  
[--] Week: 0.016% +0.00312%  
[--] Month: 0.02% +0.0024%  
[--] Months: 0.02% +0.013%  
[--] Year: 0.02% +0.011%  
1-Year High: 0.103% on 2025-07-07  
1-Year Low: 0.0017% on 2025-09-06  
  
  
### Market Dominance: 0.00524%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$apge/time-series/market_dominance.tsv)  
Current Value: 0.00524%  
Daily Average: 0%  
1-Year High: 0.207% on 2026-02-12  
1-Year Low: 0.00405% on 2025-03-25  
  
  
### Market Cap: $4,630,745,122
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$apge/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$apge/time-series/market_cap.tsv)  
Current Value: $4,630,745,122  
Daily Average: $3,089,198,843  
[--] Week: $4,584,287,366 +7.80%  
[--] Month: $4,630,745,122 -16%  
[--] Months: $4,630,745,122 +111%  
[--] Year: $4,630,745,122 +123%  
1-Year High: $5,631,636,476 on 2026-01-14  
1-Year Low: $1,672,335,008 on 2025-04-08  

### Top Apogee Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"This principle hit OX40 hard - $SNY $AMGN $APGE What about $CRVS and ITK 🤔 https://pmc.ncbi.nlm.nih.gov/articles/PMC7779661/ Good reminder to always check human LOF genetics and whether your drug phenocopies known disease biology. Evolution is the longest most underappreciated clinical trial. As noted by @Biohazard3737 https://pmc.ncbi.nlm.nih.gov/articles/PMC7779661/ Good reminder to always check human LOF genetics and whether your drug phenocopies known disease biology. Evolution is the longest most underappreciated clinical trial. As noted by @Biohazard3737"  
[X Link](https://x.com/A_May_MD/status/2022733004980760686) [@A_May_MD](/creator/x/A_May_MD) 2026-02-14T18:01Z 23.7K followers, 12.9K engagements


"@JoseRestonVA Understand 🫡 Just saw you added a couple of AD names with $KYMR $APGE $CRVS $EVMN"  
[X Link](https://x.com/tradingsssss/status/2022487921216069890) [@tradingsssss](/creator/x/tradingsssss) 2026-02-14T01:47Z [----] followers, [---] engagements


"$KYMR $CRVS $APGE Phase2b AD   ( ) Different Ph2b AD trial designs orals may take less time than injectables and close gap w/ injectable programs further ahead oral $KYMR KT-621 [--] wks [--] wk open label extension $CRVS #soquelitinib [--] wks 30-day follow-up inj $APGE $NKTR 16wk data [--] wk maintenance https://t.co/EocGY0UPie Different Ph2b AD trial designs orals may take less time than injectables and close gap w/ injectable programs further ahead oral $KYMR KT-621 [--] wks [--] wk open label extension $CRVS #soquelitinib [--] wks 30-day follow-up inj $APGE $NKTR 16wk data [--] wk maintenance"  
[X Link](https://x.com/FormalyTwilter/status/2022422074376216772) [@FormalyTwilter](/creator/x/FormalyTwilter) 2026-02-13T21:26Z [---] followers, [---] engagements


"The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt Feels like forever since the last weekly but nice to get back to work. The past week felt like a movie but important to not get distracted. Long weekend ahead with markets being closed on Monday so will use this time to get back up to speed and work on a few new ideas. $iron CRL ngl was a surprise but Im glad I passed on it even though there were rumours that approval was a foregone conclusion. $goss and $ocul should be"  
[X Link](https://x.com/seedy19tron/status/2022408965443768541) [@seedy19tron](/creator/x/seedy19tron) 2026-02-13T20:34Z 14.2K followers, 13K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing